Boaz Weinstein’s Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 MACC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-65,372
Closed -$2K 1175
2022
Q3
$2K Buy
65,372
+15,372
+31% +$1.2K ﹤0.01% 1099
2022
Q2
$4K Buy
+50,000
New +$7.71K ﹤0.01% 1086

Other funds holding MACC.WS

Boaz Weinstein's MACC.WS Position: Q4 2022 in Review

Boaz Weinstein sold out of Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (MACC.WS) in Q4 2022, closing a stake of 65,372 shares — an estimated $2K sold.

Boaz Weinstein first reported a position in MACC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 1 fund tracked by Wall St. Rank holds MACC.WS as of Q4 2022.

  • Boaz Weinstein reported no remaining Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Boaz Weinstein sold 65,372 Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $2K.
  • Boaz Weinstein first reported a position in Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • Boaz Weinstein's Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $4K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.